Core Viewpoint - Hologic, Inc. has expanded the CE marking for its Genius™ Digital Diagnostics System, allowing European labs to utilize a comprehensive solution for digital pathology workflows, enhancing the diagnosis of various cancers and diseases [1][4]. Group 1: Product Capabilities - The Genius Digital Diagnostics System can now image and review both cell and tissue specimens, previously limited to cell analysis for cervical cancer screening [1][2]. - Whole slide imaging enables the identification of pre-cancerous lesions and the review of tissue biopsies, facilitating accurate diagnoses for cervical and breast health [2][4]. - The system captures high-resolution digital images of specimens, converting them into a two-dimensional view for efficient storage and review [4][5]. Group 2: Operational Efficiency - Many labs currently use multiple systems for different sample types, leading to inefficiencies and increased operational costs [3]. - Hologic's system consolidates these processes into a single platform, potentially reducing turnaround times and streamlining lab workflows [3][5]. Group 3: Market Impact and Future Prospects - The expansion of CE marking is expected to enhance access to advanced technology in European laboratories, improving patient care [4][5]. - Hologic's innovation pipeline continues to focus on providing accurate and efficient results for disease screening and diagnosis [4][5].